Renamed to Dominari Holdings (NASDAQ:DOMH) Feb 2023
Company logo

AIKI - AIkido Pharma Inc.

NASDAQ -> Healthcare -> Biotechnology
New York, United States
Type: Equity

AIKI price evolution
AIKI
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $38.69 $42.98 $74.83 $69.76
Short term investments $16.71 $18.38 $24 $20.68
Net receivables $8.64 $8.5 $9.31 $6.98
Inventory
Total current assets $56.09 $61.56 $99.18 $90.89
Long term investments $27.19 $26.58 $18.61 $11.61
Property, plant & equipment $0.71
Goodwill & intangible assets
Total noncurrent assets $28.36 $26.73 $18.77 $11.77
Total investments $43.9 $44.96 $42.61 $32.3
Total assets $84.45 $88.3 $117.95 $102.66
Current liabilities
Accounts payable $0.52 $0.14 $0.21 $0.38
Deferred revenue
Short long term debt $0.04
Total current liabilities $1.9 $0.83 $0.9 $1.06
Long term debt $0.7
Total noncurrent liabilities $0.7
Total debt $0.74
Total liabilities $2.6 $0.83 $0.9 $1.06
Shareholders' equity
Retained earnings -$178.63 -$172.39 -$167.31 -$163.77
Other shareholder equity -$0 -$0
Total shareholder equity $81.85 $87.47 $95.05 $101.59
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $69.76 $2.71 $0.09 $0.02
Short term investments $20.68 $24.8 $0.86 $2.7
Net receivables $6.98
Inventory
Total current assets $90.89 $27.73 $1.13 $2.9
Long term investments $11.61 $2.76 $10.15 $10.35
Property, plant & equipment $0
Goodwill & intangible assets
Total noncurrent assets $11.77 $2.76 $10.15 $10.35
Total investments $32.3 $27.57 $11.01 $13.04
Total assets $102.66 $30.5 $11.28 $13.25
Current liabilities
Accounts payable $0.38 $0.57 $0.07 $0.34
Deferred revenue
Short long term debt
Total current liabilities $1.06 $0.88 $0.75 $1.15
Long term debt
Total noncurrent liabilities
Total debt
Total liabilities $1.06 $0.88 $0.75 $1.15
Shareholders' equity
Retained earnings -$163.77 -$156.6 -$144.27 -$140.08
Other shareholder equity -$0.26 -$0.26 -$0.26
Total shareholder equity $101.59 $29.62 $10.53 $12.1
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $0.59 $0.04 $2.02 $0.08
Selling, general & administrative $4.51 $2.26 $1.79 $2.5
Total operating expenses $5.1 $2.3 $3.8 $2.58
Operating income -$5.1 -$2.3 -$3.8 -$2.58
Income from continuing operations
EBIT -$6.24 -$5.08 -$6.54 -$1.81
Income tax expense
Interest expense
Net income
Net income -$6.24 -$5.08 -$6.54 -$1.81
Income (for common shares) -$6.24 -$6.18 -$6.54 -$1.81
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $0.01 $0.03
Cost of revenue
Gross Profit $0.01 $0.03
Operating activities
Research & development $1.71 $2.49 $2.52
Selling, general & administrative $7.73 $4.06 $3.17 $1.41
Total operating expenses $9.44 $6.55 $5.69 $6.9
Operating income -$9.44 -$6.55 -$5.68 -$6.87
Income from continuing operations
EBIT -$7.17 -$12.34 -$4.18 $1.73
Income tax expense
Interest expense
Net income
Net income -$7.17 -$12.34 -$4.18 $1.73
Income (for common shares) -$7.17 -$12.34 -$4.18 $1.73
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$6.24 -$5.08 -$6.54 -$1.81
Operating activities
Depreciation $0.02
Business acquisitions & disposals
Stock-based compensation $1.37 $0.1
Total cash flows from operations -$2.86 -$2.04 -$3.84 -$2.05
Investing activities
Capital expenditures
Investments -$0.16 -$5.2 -$10.17 $61.23
Total cash flows from investing -$0.68 -$5.2 -$10.08 $61.43
Financing activities
Dividends paid
Sale and purchase of stock -$0.75 -$1.51 $0.23
Net borrowings
Total cash flows from financing -$0.75 -$24.61 $18.99 $0.23
Effect of exchange rate
Change in cash and equivalents -$4.29 -$31.85 $5.08 $59.61
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$7.17 -$12.34 -$4.18 $1.73
Operating activities
Depreciation $0.04
Business acquisitions & disposals $0.9 $0.46
Stock-based compensation $0.31 $0.08 $0.33 $0.32
Total cash flows from operations -$6.6 -$4.02 -$3.02 -$2.73
Investing activities
Capital expenditures -$0.04
Investments -$4.93 -$23.95 $1.62 -$0.14
Total cash flows from investing -$8.85 -$24.96 $1.26 -$0.15
Financing activities
Dividends paid
Sale and purchase of stock $78.3 $31.61 $1.83 $2.7
Net borrowings
Total cash flows from financing $78.3 $31.61 $1.83 $2.7
Effect of exchange rate
Change in cash and equivalents $62.85 $2.62 $0.07 -$0.18
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding 5.14M
Revenue $0.00
EBITDA -$19.65M
EBIT -$19.67M
Net Income -$19.67M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio 0.00
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 0.00
Book/Share 15.92
Cash/Share 7.53
EPS -$3.83
ROA -20.00%
ROE -21.50%
Debt/Equity 0.01
Net debt/EBITDA 1.84
Current ratio 29.54
Quick ratio 29.54